SENSEX    73088.33       599.34    |    NIFTY    22147       151.15 FAQ    |    Feedback
EQUITIES
DERIVATIVES
IPO
Gainers & Losers Value & Volume Toppers 52 Weeks High/Low Advances & Declines
New High-Low
Pre-Session Mid-Session End-Session Other Markets Market Beat Stock Alert
Hot Pursuit Foreign Markets Economy News Corporate News Corporate Results
Detailed Quotes Board of Directors Balance Sheet Profit & Loss Quarterly Results Historical Price
Financial Ratios Company Background Technical Chart
Announcements Book Closure Board Meetings Bonus Issues Rights Issues
De-Listed Shares Name Change Split of Face Value Market Turnover
FII Investments MF Investments ADR Prices World Indices
Forthcoming IPOs
Open IPOs
Closed IPOs
New Listing
Basis Of Allotment Draft Prospectus New Issue Monitor
Get Quotes
Gainers
Losers
Value Toppers Advances & Declines Ticker Spot
Ticker Futures Closing Price Technical Chart Commodity News MCX Currency Futures
Get Quotes NIFTY Futures Top Traded Value Top Quantity Most Active Contracts
FII Statistics Daily Settlement Price List of Underlyings Put Call Ratio Derivative Summary
All Index Futures Top Gainers Top Losers Most Active Put Most Active Call
Highest in OI Lowest in OI Increase in OI Decrease in OI
Hot Pursuit
Scrips, which has significant changes during the market hours for last one week.
Quick Heal Tech Q3 PAT rises 6% YoY to Rs 14 cr
25-Jan-22   09:44 Hrs IST

Revenue from operations increased by nearly 14% to Rs 79.6 crore in Q3 FY22 from Rs 69.9 crore posted in Q3 FY21. Profit before tax rose 10% to Rs 19.57 crore in Q3 FY22 over Q3 FY21.

EBITDA grew by 24.4% to Rs 20.5 crore in Q3 FY22 from Rs 16.5 crore posted in the same period last year. Meanwhile, EBITDA margin grew by 216 basis points to 25.7% in Q3 FY22 from 23.6% in Q3 FY21.

The company's retail segment revenue stood at Rs 65.2 crore as compared to Rs 60.3 crore in the corresponding period of the previous year, rising 8.1% year on year. Enterprise and Government segment revenue stood at Rs 20.1 crore as compared to R 18 crore in the corresponding period previous year, up by 11.3% YoY.

Dr. Kailash Katkar, MD & CEO of Quick Heal Technologies said, “We delivered a robust third quarter in terms of revenue, subscribers, profitability and cash flow which is a testament to our team's strong execution. Our continued commitment to secure our customers' ever-increasing online footprint helped us add 818 thousand new subscribers. The growth in enterprise segment has been promising and we expect the momentum to continue in the coming quarters. In line with our strategy to boost market share, we continue to invest in R&D and strengthen leadership team that will enable us to launch next-generation solutions in the coming quarters.”

Navin Sharma, CFO of Quick Heal Technologies said, “We delivered solid results in Q3, as continued strong demand for our cybersecurity products across our diversified global go-to-market channels, coupled with our focus on operational discipline, resulted in 14% Y-o-Y growth in Revenue and 24% Y-o-Y growth in EBITDA. In line with our continued focus on R&D and innovation, we spent 27% of revenues as R&D during the quarter. Our balance sheet remains strong with zero debt and cash and cash equivalents of ₹ 3,275 million as on 31st December 2021. We are committed to driving shareholder value by growing profitability across both of our segments and driving solid Unlevered Cash Flow.”

Quick Heal Technologies is one of the leading providers of IT security and data protection solutions with a strong footprint in India and an evolving global presence.

Shares of Quick Heal were trading 5.27% lower at Rs 206.85 on BSE.

Powered by Capital Market - Live News

MARKETS
TODAY'S MARKET SECTOR
BSE NSE
Currencies
Currency EUR GBP INR USD
Europe (EUR) 1.00 0.86 89.09 1.07
United Kingdom (GBP) 1.17 1.00 104.07 1.25
India (INR) 0.01 0.01 1.00 0.01
United States (USD) 0.94 0.80 83.55 1.00
Market News << ALL News
  20-Apr-2024, (08:47 )  IREDA Q4 PAT climbs ..
  19-Apr-2024, (05:24 )  HDFC AMC Q4 PAT clim..
  19-Apr-2024, (04:41 )  Wipro Q4 PAT rises 5..
  19-Apr-2024, (04:29 )  Premier Explosives g..
 Commodities << ALL Commodities
   Attention Investor: Prevent unauthorized transactions in your trading / Demat account : Update your mobile number / e mail ids with your stock broker / deposit." | "No need to issue cheques by investors while subscribing to IPO.Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor’s account." | "KYC is one time exercise while dealing in securities markets- once KYC is done through a SEBI registered intermediary(broker, DP, Mutual Fund etc.) you need not undergo the same process again when you approach another intermediary."
   Disclaimer   |   BSE Disclosure  |  Privacy Policy   |   Investor Protection   |    Inactive Account   |  Vernacular Language: NSE | BSE   |   Feedback   |    PMLA Policy   |   Risk Management Policy   |   Insider Trading   |   Investor Grivenances   |   Investor Complaints   |   Investor Charter   |   Rules And Regulations   |   Broker Norms   |   Terms of Use    Policies & Procedures   |   Risk Disclosure   |   Do & Don’ts   |   Rights & Obligations
  
SEBI Registration No : INZ000267132   |   BSE Clearing No : 333   
   Copyright © 2011 All rights reserved by Jaysukhlal Jagjivan Stock Broking Pvt.Ltd Designed, Developed & Powered By CMOTS INFOTECH (ISO 9001:2015 certified)